Valayannopoulos V, Nicely H, Harmatz P, Turbeville S: Mucopolysaccharidosis VI. Orphanet J Rare Dis. 2010, 5: 5-24. 10.1186/1750-1172-5-5.
Article
PubMed Central
PubMed
Google Scholar
Saito S, Ohno K, Sekijima M, Suzuki T, Sakuraba H: Database of the clinical phenotypes, genotypes and mutant arylsulfatase B structures in mucopolysaccharidosis type VI. J Hum Genet. 2012, 57 (4): 280-282. 10.1038/jhg.2012.6.
Article
CAS
PubMed
Google Scholar
Harmatz P, Giugliani R, Schwartz IV, Guffon N, Teles EL, Miranda MC, Wraith JE, Beck M, Arash L, Scarpa M, Ketteridge D, Hopwood JJ, Plecko B, Steiner R, Whitley CB, Kaplan P, Yu ZF, Swiedler SJ, Decker C, MPS VI Study Group: Long-term follow-up of endurance and safety outcomes during enzyme replacement therapy for mucopolysaccharidosis VI: final results of three clinical studies of recombinant human N-acetylgalactosamine 4-sulfatase. Mol Genet Metab. 2008, 94 (4): 469-475. 10.1016/j.ymgme.2008.04.001.
Article
CAS
PubMed
Google Scholar
Harmatz P, Giugliani R, Schwartz I, Guffon N, Teles EL, Miranda MC, Wraith JE, Beck M, Arash L, Scarpa M, Yu ZF, Wittes J, Berger KI, Newman MS, Lowe AM, Kakkis E, Swiedler SJ, MPS VI Phase 3 Study Group: Enzyme replacement therapy for mucopolysaccharidosis VI: a phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-label extension study. J Pediatr. 2006, 148 (4): 533-539. 10.1016/j.jpeds.2005.12.014.
Article
CAS
PubMed
Google Scholar
Harmatz P, Yu ZF, Giugliani R, Schwartz IV, Guffon N, Teles EL, Miranda MC, Wraith JE, Beck M, Arash L, Scarpa M, Ketteridge D, Hopwood JJ, Plecko B, Steiner R, Whitley CB, Kaplan P, Swiedler SJ, Hardy K, Berger KI, Decker C: Enzyme replacement therapy for mucopolysaccharidosis VI: evaluation of long-term pulmonary function in patients treated with recombinant human N-acetylgalactosamine 4-sulfatase. J Inherit Metab Dis. 2010, 33 (1): 51-60. 10.1007/s10545-009-9007-8.
Article
CAS
PubMed Central
PubMed
Google Scholar
Brooks DA, Kakavanos R, Hopwood JJ: Significance of immune response to enzyme-replacement therapy for patients with a lysosomal storage disorder. Trends Mol Med. 2003, 9 (10): 450-453. 10.1016/j.molmed.2003.08.004.
Article
CAS
PubMed
Google Scholar
Hollak CE, Linthorst GE: Immune response to enzyme replacement therapy in Fabry disease: impact on clinical outcome?. Mol Genet Metab. 2009, 96 (1): 1-3. 10.1016/j.ymgme.2008.10.013.
Article
CAS
PubMed
Google Scholar
Banugaria SG, Prater SN, Ng YK, Kobori JA, Finkel RS, Ladda RL, Chen YT, Rosenberg AS, Kishnani PS: The impact of antibodies on clinical outcomes in diseases treated with therapeutic protein: lessons learned from infantile Pompe disease. Genet Med. 2011, 13 (8): 729-736. 10.1097/GIM.0b013e3182174703.
Article
CAS
PubMed Central
PubMed
Google Scholar
Baum H, Dodgson KS, Spencer B: The assay of arylsulphatases A and B in human urine. Clin Chim Acta. 1959, 4 (3): 453-455. 10.1016/0009-8981(59)90119-6.
Article
CAS
PubMed
Google Scholar
Garrido E, Cormand B, Hopwood JJ, Chabas A, Grinberg D, Vilageliu L: Maroteaux-Lamy syndrome: functional characterization of pathogenic mutations and polymorphisms in the arylsulfatase B gene. Mol Genet Metab. 2008, 94 (3): 305-312. 10.1016/j.ymgme.2008.02.012.
Article
CAS
PubMed
Google Scholar
Hasilik A, Neufeld EF: Biosynthesis of lysosomal enzymes in fibroblasts. Synthesis as precursors of higher molecular weight. J Biol Chem. 1980, 255 (10): 4937-4945.
CAS
PubMed
Google Scholar
Litjens T, Brooks DA, Peters C, Gibson GJ, Hopwood JJ: Identification, expression, and biochemical characterization of N-acetylgalactosamine-4-sulfatase mutations and relationship with clinical phenotype in MPS-VI patients. Am J Hum Genet. 1996, 58 (6): 1127-1134.
CAS
PubMed Central
PubMed
Google Scholar
Litjens T, Hopwood JJ: Mucopolysaccharidosis type VI: Structural and clinical implications of mutations in N-acetylgalactosamine-4-sulfatase. Hum Mutat. 2001, 18 (4): 282-295. 10.1002/humu.1190.
Article
CAS
PubMed
Google Scholar
Jurecka A, Piotrowska E, Cimbalistiene L, Gusina N, Sobczynska A, Czartoryska B, Czerska K, Ounap K, Wegrzyn G, Tylki-Szymanska A: Molecular analysis of mucopolysaccharidosis type VI in Poland, Belarus, Lithuania and Estonia. Mol Genet Metab. 2012, 105 (2): 237-243. 10.1016/j.ymgme.2011.11.003.
Article
CAS
PubMed
Google Scholar
Costa-Motta FM, Acosta AX, Abe-Sandes K, Bender F, Schwartz IV, Giugliani R, Leistner-Segal S: Genetic studies in a cluster of mucopolysaccharidosis type VI patients in Northeast Brazil. Mol Genet Metab. 2011, 104 (4): 603-607. 10.1016/j.ymgme.2011.09.017.
Article
CAS
PubMed
Google Scholar
Yang CF, Wu JY, Lin SP, Tsai FJ: Mucopolysaccharidosis type VI: Report of two Taiwanese patients and identification of one novel mutation. J Formos Med Assoc. 2001, 100 (12): 820-823.
CAS
PubMed
Google Scholar
Voskoboeva E, Isbrandt D, von Figura K, Krasnopolskaya X, Peters C: Four novel mutant alleles of the arylsulfatase B gene in two patients with intermediate form of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome). Hum Genet. 1994, 93 (3): 259-264. 10.1007/BF00212019.
Article
CAS
PubMed
Google Scholar
Gottwald I, Hughes J, Stewart F, Tylee K, Church H, Jones SA: Attenuated mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome) due to homozygosity for the p.Y210C mutation in the ARSB gene. Mol Genet Metab. 2011, 103 (3): 300-302. 10.1016/j.ymgme.2011.03.024.
Article
CAS
PubMed
Google Scholar
Karageorgos L, Brooks DA, Pollard A, Melville EL, Hein LK, Clements PR, Ketteridge D, Swiedler SJ, Beck M, Giugliani R, Harmatz P, Wraith JE, Guffon N, Leao Teles E, Sa Miranda MC, Hopwood JJ: Mutational analysis of 105 mucopolysaccharidosis type VI patients. Hum Mutat. 2007, 28 (9): 897-903. 10.1002/humu.20534.
Article
CAS
PubMed
Google Scholar
Hopwood JJ, Elliott H, Muller VJ, Saccone GT: Diagnosis of Maroteaux-Lamy syndrome by the use of radiolabelled oligosaccharides as substrates for the determination of arylsulphatase B activity. Biochem J. 1986, 234 (3): 507-514.
Article
CAS
PubMed Central
PubMed
Google Scholar
Brooks DA, McCourt PA, Gibson GJ, Ashton LJ, Shutter M, Hopwood JJ: Analysis of N-acetylgalactosamine-4-sulfatase protein and kinetics in mucopolysaccharidosis type VI patients. Am J Hum Genet. 1991, 48 (4): 710-719.
CAS
PubMed Central
PubMed
Google Scholar
Swiedler SJ, Beck M, Bajbouj M, Giugliani R, Schwartz I, Harmatz P, Wraith JE, Roberts J, Ketteridge D, Hopwood JJ, Guffon N, Sa Miranda MC, Teles EL, Berger KI, Piscia-Nichols C: Threshold effect of urinary glycosaminoglycans and the walk test as indicators of disease progression in a survey of subjects with Mucopolysaccharidosis VI (Maroteaux-Lamy syndrome). Am J Med Genet A. 2005, 134A (2): 144-150. 10.1002/ajmg.a.30579.
Article
PubMed
Google Scholar
Jurecka A, Golda A, Opoka-Winiarska V, Piotrowska E, Tylki-Szymanska A: Mucopolysaccharidosis Type VI (Maroteaux-Lamy syndrome) with a predominantly cardiac phenotype. Mol Genet Metab. 2011, 104 (4): 695-9. 10.1016/j.ymgme.2011.08.024.
Article
CAS
PubMed
Google Scholar
Mount SM: A catalogue of splice junction sequences. Nucleic Acids Res. 1982, 10 (2): 459-472. 10.1093/nar/10.2.459.
Article
CAS
PubMed Central
PubMed
Google Scholar
Thumler A, Miebach E, Lampe C, Pitz S, Kamin W, Kampmann C, Link B, Mengel E: Clinical characteristics of adults with slowly progressing mucopolysaccharidosis VI: a case series. J Inherit Metab Dis. 2012, 35 (6): 1071-9. 10.1007/s10545-012-9474-1.
Article
PubMed
Google Scholar
Arlt G, Brooks DA, Isbrandt D, Hopwood JJ, Bielicki J, Bradford TM, Bindloss-Petherbridge CA, von Figura K, Peters C: Juvenile form of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome). A C-terminal extension causes instability but increases catalytic efficiency of arylsulfatase B. J Biol Chem. 1994, 269 (13): 9638-9643.
CAS
PubMed
Google Scholar
Ellgaard L, Helenius A: Quality control in the endoplasmic reticulum. Nat Rev Mol Cell Biol. 2003, 4 (3): 181-191.
Article
CAS
PubMed
Google Scholar
Bradford TM, Litjens T, Parkinson EJ, Hopwood JJ, Brooks DA: Mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome): a Y210C mutation causes either altered protein handling or altered protein function of N-acetylgalactosamine 4-sulfatase at multiple points in the vacuolar network. Biochemistry. 2002, 41 (15): 4962-4971. 10.1021/bi0121149.
Article
CAS
PubMed
Google Scholar
Brands MM, Oussoren E, Ruijter GJ, Vollebregt AA, van den Hout HM, Joosten KF, Hop WC, Plug I, van der Ploeg AT: Up to five years experience with 11 mucopolysaccharidosis type VI patients. Mol Genet Metab. 2013, 10.1016/j.ymgme.2013.02.013.
Google Scholar
Deegan PB: Fabry disease, enzyme replacement therapy and the significance of antibody responses. J Inherit Metab Dis. 2012, 35 (2): 227-243. 10.1007/s10545-011-9400-y.
Article
CAS
PubMed
Google Scholar